证券代码：001231 证券简称：农心科技 公告编号：2024-052 三、本次募集资金专户的变更情况 农心作物科技股份有限公司 关于募集资金专户变更完成、签订募集资金监管协议的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、 误导性陈述或重大遗漏。 一、募集资金基本情况 经中国证券监督管理委员会《关于核准农心作物科技股份有限公司首次公开 发行股票的批复》（证监许可[2022]1125 号）核准，农心作物科技股份有限公司 （以下简称"公司"或"农心科技"）首次公开发行人民币普通股（A 股）股票 2,500.00 万股，每股面值 1 元，每股发行价格为人民币 17.77 元，募集资金总额 444,250,000.00 元，减除发行费用人民币 67,858,200.00 元后，募集资金净额为 376,391,800.00 元。募集资金已于 2022 年 8 月 15 日划至公司指定账户。天健会 计师事务所（特殊普通合伙）已于 2022 年 8 月 15 日对公司首次公开发行股票的 资金到位情况进行了审验，并出具了《验资报告》（天健验[2022]421 号）。 二、募集资金存放与管理情 ...

华泰联合证券有限责任公司 关于农心作物科技股份有限公司 变更部分募集资金专户的核查意见 华泰联合证券有限责任公司（以下简称"华泰联合证券"或"保荐人"）作为 农心作物科技股份有限公司（以下简称"农心科技"或"公司"）首次公开发行股 票并上市持续督导阶段的保荐人，根据《证券发行上市保荐业务管理办法》《深 圳证券交易所上市公司自律监管指引第 1 号——主板上市公司规范运作》《上市 公司监管指引第 2 号——上市公司募集资金管理和使用的监管要求》等相关法律 法规和规范性文件的规定，对公司变更部分募集资金专户的事项进行了核查，并 出具本核查意见如下： 公司于 2024 年 8 月 27 日召开了第二届董事会第四次独立董事专门会议，审 议通过了《关于变更部分募集资金专户并授权办理有关事项的议案》，经审议， 独立董事认为：公司本次变更部分募集资金专户等有关事项，符合《上市公司监 管指引第 2 号——上市公司募集资金管理和使用的监管要求》《深圳证券交易所 股票上市规则》《深圳证券交易所上市公司自律监管指引第 1 号——主板上市公 司规范运作》等有关法律法规及《农心作物科技股份有限公司募集资金管理制度》 等相关制度规定，有利 ...

证券代码：001231 证券简称：农心科技 公告编号：2024-050 农心作物科技股份有限公司 关于召开2024年第二次临时股东大会的通知 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、 误导性陈述或重大遗漏。 一、召开会议的基本情况 1．股东大会届次 2024年第二次临时股东大会。 2．股东大会的召集人 本次股东大会由农心作物科技股份有限公司（以下简称"公司"）董事会召 集。公司于2024年8月27日召开的第二届董事会第十六次会议审议通过了《关于 提请召开2024年第二次临时股东大会的议案》。 3．会议召开的合法性、合规性 本次股东大会的召开符合相关法律、行政法规、部门规章、规范性文件、深 圳证券交易所业务规则和公司章程等规定。 4．会议召开时间： （1）现场会议召开时间：2024年9月13日15：00。 （2）网络投票时间： 通过深圳证券交易所交易系统网络投票时间：2024年9月13日9:15-9:25, 9:30-11:30和13:00-15:00； 通过深圳证券交易所互联网投票时间：2024年9月13日9:15-15:00。 5．会议的召开方式 本次股东大会采用现场表决与网 ...

证券代码：001231 证券简称：农心科技 公告编号：2024-047 农心作物科技股份有限公司 关于公司部分募投项目延期的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记 载、误导性陈述或重大遗漏。 农心作物科技股份有限公司（以下简称"公司"或"农心科技"）于 2024 年 8 月 27 日召开了第二届董事会第四次独立董事专门会议、第二届董事会第十六 次会议和第二届监事会第十四次会议，审议通过了《关于公司部分募投项目延期 的议案》，同意公司根据募投项目的实际建设情况及目前实施进度，对公司首次 公开发行股票募集资金投资项目之"绿色农药制剂智能数字化工厂技术改造项目" （以下简称"技改项目"）、"研发中心项目"及"营销服务体系建设项目"达到 预定可使用状态日期进行延期。根据《深圳证券交易所上市公司自律监管指引第 1 号——主板上市公司规范运作》等相关规定，该议案无需提交公司股东大会审 议。现将有关情况公告如下： 一、募集资金基本情况 公司根据《农心作物科技股份有限公司募集资金管理办法》，对募集资金实 行专户存储，在银行设立募集资金专户，并连同保荐人华泰联合证券有限责任公 司于 2022 ...

证券代码：001231 证券简称：农心科技 公告编号：2024- 043 农心作物科技股份有限公司 第二届监事会第十四次会议决议的公告 本公司及监事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记 载、误导性陈述或重大遗漏。 农心作物科技股份有限公司（以下简称"公司"）第二届监事会第十四次会 议于 2024 年 8 月 16 日以电子邮件方式发出会议通知，于 2024 年 8 月 27 日在 公司会议室召开。本次会议应到监事 3 名，实到监事 3 名，全体监事均于会议现 场参会并表决，公司董事会秘书列席本次会议。 本次会议的召集、召开和表决程序符合《中华人民共和国公司法》《农心作 物科技股份有限公司章程》《农心作物科技股份有限公司监事会议事规则》以及 有关法律法规的规定，各位监事确认对本次会议的召集、召开方式无异议。本次 会议由监事会主席龙国伟先生主持，与会监事对本次会议的全部议案进行了充分 讨论，审慎表决，形成如下决议： 具体内容详见公司同日于巨潮资讯网（www.cninfo.com.cn）发布的《农心 作物科技股份有限公司 2024 年半年度报告》及《农心作物科技股份有限公司 2024 年半年度报 ...

华泰联合证券有限责任公司关于 农心作物科技股份有限公司 使用部分暂时闲置募集资金进行现金管理的核查意见 华泰联合证券有限责任公司（以下简称"华泰联合证券"或"保荐人"）作 为农心作物科技股份有限公司（以下简称"农心科技"或"公司"）首次公开发行 股票并上市持续督导阶段的保荐人，根据《证券发行上市保荐业务管理办法》《深 圳证券交易所上市公司自律监管指引第 1 号——主板上市公司规范运作》《上市 公司监管指引第 2 号——上市公司募集资金管理和使用的监管要求》等相关法律 法规和规范性文件的规定，对公司使用部分暂时闲置募集资金进行现金管理事项 进行了核查，并出具本核查意见如下： 一、募集资金基本情况 经中国证券监督管理委员会《关于核准农心作物科技股份有限公司首次公开 发行股票的批复》（证监许可[2022]1125 号）核准，农心科技首次公开发行人民 币普通股（A 股）股票 2,500.00 万股，每股面值 1 元，每股发行价格为人民币 17.77 元，募集资金总额 444,250,000.00 元，减除发行费用人民币 67,858,200.00 元后，募集资金净额为 376,391,800.00 元。募集资金已于 ...

Financial Performance - Revenue for the reporting period was RMB 392.46 million, a 4.57% increase compared to the same period last year[12] - Net profit attributable to shareholders of the listed company was RMB 42.70 million, a slight increase of 0.52% year-over-year[12] - Operating cash flow was negative RMB 71.36 million, a 49.00% decrease compared to the same period last year[12] - Total assets at the end of the reporting period were RMB 1.41 billion, a 4.29% increase compared to the end of the previous year[12] - Revenue for the first half of 2024 reached 392.46 million yuan, a 4.6% increase compared to 375.32 million yuan in the same period of 2023[113] - Operating profit for the first half of 2024 was 48.98 million yuan, up 5.0% from 46.65 million yuan in the first half of 2023[113] - Net profit attributable to parent company shareholders in the first half of 2024 was 42.70 million yuan, a slight increase from 42.48 million yuan in the same period of 2023[114] - R&D expenses increased by 27.3% to 22.16 million yuan in the first half of 2024, compared to 17.41 million yuan in the first half of 2023[113] - Basic earnings per share for the first half of 2024 was 0.43 yuan, up from 0.42 yuan in the same period of 2023[114] - Interest income rose by 56.0% to 6.05 million yuan in the first half of 2024, compared to 3.88 million yuan in the first half of 2023[113] - Other income increased significantly to 2.31 million yuan in the first half of 2024, up from 463,074.67 yuan in the same period of 2023[113] - Sales expenses grew by 9.2% to 39.48 million yuan in the first half of 2024, compared to 36.15 million yuan in the first half of 2023[113] - Operating costs increased by 4.5% to 266.39 million yuan in the first half of 2024, up from 254.80 million yuan in the same period of 2023[113] - The company's financial expenses showed a net income of 5.13 million yuan in the first half of 2024, compared to 3.11 million yuan in the same period of 2023[113] - Operating cash flow from sales of goods and services decreased to 182.72 million yuan in H1 2024 from 203.88 million yuan in H1 2023, a decline of 10.4%[117] - Net cash flow from operating activities was negative 71.36 million yuan in H1 2024, worsening from negative 47.89 million yuan in H1 2023[117] - Cash received from investment returns increased significantly to 361,743.76 yuan in H1 2024 from 98,630.14 yuan in H1 2023, a 266.8% increase[117][119] - Net cash flow from investing activities improved to negative 123.35 million yuan in H1 2024 from negative 136.37 million yuan in H1 2023[118] - Cash and cash equivalents at the end of H1 2024 decreased to 245.01 million yuan from 471.17 million yuan at the beginning of the period, a 48.0% decline[118] - Parent company's operating cash flow from sales of goods and services decreased to 177.93 million yuan in H1 2024 from 185.60 million yuan in H1 2023, a 4.1% decline[119] - Parent company's net cash flow from investing activities worsened to negative 163.26 million yuan in H1 2024 from negative 96.57 million yuan in H1 2023[120] - Parent company's cash and cash equivalents at the end of H1 2024 decreased to 203.43 million yuan from 415.32 million yuan at the beginning of the period, a 51.0% decline[120] - Total owner's equity at the end of H1 2024 was 952.88 million yuan, with minority interests accounting for 12.07 million yuan[121] - The company's total comprehensive income for the current period is RMB 427,030,499.11[122] - The company's total owner's equity at the end of the period is RMB 965,689,920.05[123] - The company's undistributed profit increased by RMB 22,484,137.52 during the current period[124] - The company allocated RMB 20,000,000.00 for profit distribution to owners (or shareholders)[125] - The company's total owner's equity at the end of the period is RMB 944,681,783.25[126] - The company's total owner's equity at the beginning of the period was 823,496,516.58 yuan, with a capital reserve of 525,694,249.30 yuan and undistributed profits of 154,587,040.55 yuan[127] - During the period, the company's comprehensive income totaled 33,433,765.80 yuan, contributing to the increase in owner's equity[127] - The company allocated 7,898,219.60 yuan for profit distribution to owners (or shareholders), reducing the owner's equity accordingly[128] - At the end of the period, the company's total owner's equity increased to 829,026,448.48 yuan, with undistributed profits rising to 180,122,586.75 yuan[128] - In the previous year, the company's total owner's equity was 798,843,712.90 yuan, with undistributed profits of 134,399,517.24 yuan[129] - The company's comprehensive income for the previous period was 33,546,560.50 yuan, contributing to the increase in owner's equity[130] - The company allocated 20,000,000.00 yuan for profit distribution to owners (or shareholders) in the previous period, reducing the owner's equity accordingly[130] - At the end of the previous period, the company's total owner's equity increased to 812,390,273.40 yuan, with undistributed profits rising to 147,946,077.74 yuan[131] Dividend and Profit Distribution - The company plans to distribute a cash dividend of 0.5 yuan per 10 shares, based on 100,000,000 shares, with no stock dividend or capital reserve conversion[2] - The company proposed a cash dividend of RMB 0.5 per 10 shares, totaling RMB 5,000,000, accounting for 100% of the total profit distribution[67] - The company's total distributable profits as of June 30, 2024, were RMB 299,077,315.66[67] - The company completed the 2023 profit distribution, distributing 0.80 yuan per 10 shares, with a total of 98,575,445 shares as the base[87] - The company proposed a 2024 interim profit distribution plan of 0.50 yuan per 10 shares, based on 100 million shares[88] Subsidiaries and Business Operations - The company's subsidiaries include Shaanxi Shangge Road Biological Science Co., Ltd., Shaanxi Bencai Agricultural Development Co., Ltd., and Myanmar Shangge Road Biological Science Co., Ltd., among others[5] - The company's main business focuses on the R&D, production, and sales of pesticide formulations, with product categories including insecticides, fungicides, and herbicides[16] - The company's subsidiary, Shaanxi Shangge Road Biological Science Co., Ltd., reported total assets of 740,088,413.93 yuan, net assets of 357,647,664.39 yuan, and operating income of 285,959,443.71 yuan, with a net profit of 7,508,279.03 yuan[53] - The company established a new subsidiary, SUNGAR AGRI-TECH(PRIVATE) LIMITED, in Pakistan, which has obtained legal registration documents but is still undergoing domestic filing procedures[53] - The company's subsidiary, Jianyi Zhiyuan API project, is expected to increase production capacity, but there is a risk of market promotion not keeping pace with rapid capacity expansion[58] - The company has 7 subsidiaries included in the consolidated financial statements for the reporting period[132] Industry and Market Trends - China's GDP grew by 5.0% year-over-year in the first half of 2024, with the secondary industry contributing 43.6% to economic growth[16] - High-tech manufacturing investment increased by 10.1% year-over-year, driving the development of high-tech industries[17] - Final consumption expenditure contributed 60.5% to economic growth, driving GDP growth by 3.0 percentage points[17] - The revenue of information transmission, software, and IT services enterprises above designated size increased by 11.2% from January to May, 2.7 percentage points higher than the overall service industry[18] - Online retail sales of physical goods grew by 8.8% year-on-year in the first half of the year, 5.1 percentage points higher than the total retail sales of consumer goods, accounting for 25.3% of the total retail sales of consumer goods, an increase of 2.0 percentage points from the first quarter[18] - The "14th Five-Year Plan" for the national pesticide industry aims to reduce the number of pesticide production enterprises from 1,705 in 2020 to less than 1,600 by 2025, fostering 10 enterprises with output value exceeding 5 billion yuan, 50 enterprises exceeding 1 billion yuan, and 100 enterprises exceeding 500 million yuan[20] - The pesticide industry faced a downturn in 2023 with stable terminal market demand and low upstream raw material prices, leading to a decline in terminal product prices and increased inventory pressure[21] - The commercialization of genetically modified crops is advancing, with pilot applications of herbicide-tolerant transgenic soybeans and insect-resistant, herbicide-tolerant transgenic corn accelerating, impacting related herbicide products like glyphosate and glufosinate[21] - Large-scale farmers are emerging as a key force in agriculture, promoting the use of scientific farming practices and high-quality, low-toxicity, and low-residue chemical pesticides[21] - The application of new technologies such as drones, IoT, and big data is making agricultural production more efficient and intelligent, attracting more young people to the industry[21] - The "Innovative Development Implementation Plan for the Fine Chemical Industry (2024-2027)" emphasizes the need for the pesticide industry to accelerate innovation, improve product quality and safety, and phase out high-residue pesticides[19] - The "Pesticide Label and Instructions Management Measures (Revised Draft for Comments)" proposes that a single production enterprise can only use one brand logo or trademark, potentially prompting industry adjustments and upgrades[18] - The "Food Safety National Standard for Maximum Residue Limits of 112 Pesticides in Food" (GB 2763.1-2022) sets 290 maximum residue limits for 112 pesticides in various foods, enhancing food quality and safety[18] Research and Development - R&D investment increased by 27.29% to 22,156,290.60 yuan, reflecting a significant focus on innovation[30] - The company owns 213 invention patents and 311 pesticide registration certificates as of the reporting period[25] - The company's subsidiary, Shangge Road, has been continuously recognized as a national high-tech enterprise since 2009[25] - The company's product "0.06% Sterol Microemulsion" was included in the "First Batch of Green High-Quality Pesticide Products List" by the China Pesticide Industry Association in March 2022[25] - The company has a comprehensive QA/QC inspection system and advanced testing instruments to ensure product quality[27] - The company continuously develops and launches new pesticide formulation products annually, leveraging the strong brand effect of "Shangge"[29] - Research and development expenses include personnel costs, direct input costs, depreciation, and amortization of intangible assets used in R&D activities[175][176] Financial Position and Assets - Total assets at the end of the reporting period were RMB 1.41 billion, a 4.29% increase compared to the end of the previous year[12] - The company's monetary funds decreased by 15.00% to 302,475,742.56 yuan, mainly due to investments in bank deposits and financial products[33] - Accounts receivable increased by 9.85% to 215,968,920.67 yuan, reflecting the peak business season with unsettled payments[33] - The company's financial assets, including trading financial assets, totaled 192,200,000.00 yuan at the end of the reporting period[35] - Restricted assets included 56,457,947.70 yuan in monetary funds and 74,509,930.86 yuan in construction in progress, primarily due to bank loan guarantees[36] - The company's inventory balance at the end of the reporting period was 96.52 million yuan, accounting for 11.65% of current assets, primarily due to targeted stockpiling to meet market demand[56] - The company's operating gross margin for the reporting period was 32.12%, with raw material costs constituting a significant portion of operating costs, posing a risk of margin decline[60] - The company's monetary funds decreased from 493,052,240.16 yuan to 302,475,742.56 yuan, a decrease of 38.7%[106] - Accounts receivable increased from 73,823,212.83 yuan to 215,968,920.67 yuan, an increase of 192.6%[106] - Inventory decreased from 120,907,573.01 yuan to 96,523,380.60 yuan, a decrease of 20.2%[106] - Other current assets decreased from 115,342,050.07 yuan to 34,330,893.05 yuan, a decrease of 70.2%[106] - Total current assets decreased from 843,162,984.27 yuan to 828,234,156.82 yuan, a decrease of 1.8%[106] - Fixed assets decreased from 166,409,151.93 yuan to 161,002,235.16 yuan, a decrease of 3.2%[107] - Construction in progress increased from 236,218,999.73 yuan to 273,369,767.33 yuan, an increase of 15.7%[107] - Total non-current assets increased from 510,313,400.02 yuan to 583,278,127.71 yuan, an increase of 14.3%[107] - Total assets increased from 1,353,476,384.29 yuan to 1,411,512,284.53 yuan, an increase of 4.3%[107] - Total liabilities increased to 445,822,364.48 RMB, up 11.3% from 400,597,865.63 RMB in the previous period[108] - Current liabilities rose to 335,664,315.63 RMB, a 21.9% increase from 275,438,914.09 RMB[108] - Long-term liabilities decreased to 110,158,048.85 RMB, down 12.0% from 125,158,951.54 RMB[108] - Owner's equity increased to 965,689,920.05 RMB, up 1.3% from 952,878,518.66 RMB[108] - Monetary funds decreased to 260,895,100.12 RMB, down 40.3% from 437,203,235.49 RMB[110] - Accounts receivable surged to 196,532,623.42 RMB, a 206.3% increase from 64,161,382.23 RMB[110] - Inventory grew to 5,938,988.57 RMB, a 342.4% increase from 1,342,798.03 RMB[110] - Total current assets increased to 612,464,656.54 RMB, up 3.1% from 593,945,057.01 RMB[110] - Non-current assets rose to 579,985,897.41 RMB, a 26.6% increase from 458,234,567.73 RMB[110] Investments and Projects - Total investment in the reporting period was RMB 42.75 million, a 34.29% increase compared to the same period last year[38] - The green pesticide and intermediate R&D base project has a cumulative investment of RMB 313.45 million, with a project progress of 85.10%[38] - The company headquarters and R&D center project has a cumulative investment of RMB 62.95 million, with a project progress of 31.05%[38] - The green pesticide formulation intelligent digital factory project has a cumulative investment of RMB 10.49 million, with a project progress of 30.45%[38] - The marketing service system construction project has a cumulative investment of RMB 2.50 million, with a project progress of 5.92%[39] - Total raised funds amount to RMB 376.39 million, with RMB 195.78 million already utilized, representing 52.02% of the total[43] - The green pesticide formulation intelligent digital factory project has an adjusted investment of RMB 42.69 million, with a cumulative investment of RMB 10.49 million, representing 24.57% of the adjusted total[44] - The R&D center project has an adjusted investment of RMB 171.40 million, with a cumulative investment of RMB 62.79 million, representing 36.63% of the adjusted total[44] - The marketing service system construction project has a cumulative investment of RMB 2.50 million, representing 5.92% of the total investment[44] - The supplementary working capital project has been fully utilized with a total investment of RMB 120.00 million[44] - The company adjusted the use of funds for the "Green Pesticide Formulation Intelligent Digital Factory Technical Transformation Project" to 17,140.38 million yuan, with a delay in implementation due to approval and construction processes[45] - The "Marketing Service System Construction Project" was changed from purchasing or leasing to self-construction, leading to delays due to longer construction time[45] - The unused raised funds amount to 18,921.38 million yuan, with 8,000 million yuan allocated for structured deposits[46] - The "Green Pesticide Formulation Intelligent Digital Factory Technical Transformation Project" has an investment progress of 24.57% as of the reporting period[48] - The "R&D Center Project"

农心作物科技股份有限公司 关于变更部分募集资金专户并授权办理有关事项的公告 证券代码：001231 证券简称：农心科技 公告编号：2024-049 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、 误导性陈述或重大遗漏。 农心作物科技股份有限公司（以下简称"公司"或"农心科技"）于 2024 年 8 月 27 日召开了第二届董事会第四次独立董事专门会议、第二届董事会第十六 次会议和第二届监事会第十四次会议，审议通过了《关于变更部分募集资金专户 并授权办理有关事项的议案》，同意公司变更部分募集资金专户并授权办理有关 事项。 公司独立董事专门会议、监事会对此事项发表了明确的同意意见，保荐人华 泰联合证券有限责任公司（以下简称"保荐人"）对此事项出具了核查意见。现 将相关事项公告如下： 一、募集资金基本情况 经中国证券监督管理委员会《关于核准农心作物科技股份有限公司首次公开 发行股票的批复》（证监许可[2022]1125 号）核准，农心作物科技股份有限公司 （以下简称"公司"）首次公开发行人民币普通股（A 股）股票 2,500.00 万股，每 股面值 1 元，每股发行价格为人民币 17.77 ...

（本页无正文，为《农心作物科技股份有限公司2024年半年度非经营性资金占用及其他关联资金往来情况汇总表》之签章页） 法定代表人：郑敬敏 主管会计工作负责人：刘永孝 会计机构负责人：高生金 农心作物科技股份有限公司 2024年8月28日 2024年半年度非经营性资金占用及其他关联资金往来情况汇总表 单位：人民币万元 | 非经营性资金占用 | 资金占用方名称 | 占用方与公司 的关联关系 | 公司核算的 | 2024年期初占 | 2024年半年度占用 | 2024年半年度占用 | 2024年半年度偿还 | 2024年半年度期末 | 占用形成 | 占用性质 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | | | | 会计科目 | 用资金余额 | 累计发生金额（不 | 资金的利息（如 | 累计发生金额 | 占用资金余额 | 原因 | | | | | | | | 含利息） | 有） | | | | | | 控股股东、实际控制人及其 | | | | | | | | | | 非经营性占用 | | 附属企业 | | | | | | ...

证券代码：001231 证券简称：农心科技 公告编号：2024-045 农心作物科技股份有限公司 关于2024年半年度利润分配预案的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、 误导性陈述或重大遗漏。 农心作物科技股份有限公司（以下简称"公司"）于 2024 年 8 月 27 日召开 第二届董事会第四次独立董事专门会议、第二届董事会第十六次会议、第二届监 事会第十四次会议，审议通过了《关于 2024 年半年度利润分配预案的议案》， 该预案尚需提交公司 2024 年第二次临时股东大会审议。现将该预案的基本情况 公告如下： 一、2024 年半年度利润分配预案基本内容 根据公司财务报告（未经审计），截至 2024 年 6 月 30 日，公司 2024 年半 年度合并报表归属于母公司股东的净利润为 42,703,049.91 元，公司合并报表可 供股东分配的利润为 299,077,315.66 元。其中母公司 2024 年半年度实现的净利 润为人民币 33,433,765.80 元，母公司截至 2024 年 6 月 30 日可供股东分配的利 润为人民币 180,122,586.75 ...